Posted by ABMN Staff on Apr 16th, 2024
Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) CEO Samuel Kintz sold 47,709 shares of Enliven Therapeutics stock in a transaction dated Thursday, April 11th. The shares were sold at an average price of $25.04, for...
More of this article »